Search
for
Sort by
Research 91–120 of 1000+
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- Immunology of the Human Nail Apparatus: The Nail Matrix Is a Site of Relative Immune Privilege
- Virilization in a postmenopausal woman: Ovarian Leydig cell tumor
- Hirsutism in the Adolescent Female
- Hormonal Therapy for Acne
- The Case of the Elusive Androgen
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- The use of topical minoxidil to accelerate nail growth: a pilot study
- The Hirsute Woman: Challenges in Evaluation and Management
- Hirsutism
- Trilostane Treatment of Canine Alopecia X in an American Pit Bull Terrier
- Gonads
- Dopa oxidase activity in the hair, skin and ocular melanocytes is increased in the presence of stressed fibroblasts
- Current evaluation of amenorrhea
- A Case Report of Cushing’s Disease Presenting as Hair Loss
- How should postmenopausal androgen excess be evaluated?
- Androgens in women
- Adult Acne
- Hirsutism: Diagnosis and management
- Ovarian and Adrenal Androgens and Their Link to High Human Chorionic Gonadotropin Levels: A Prospective Controlled Study
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report
- Polycystic ovarian syndrome
- MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment
- Clinical Management in Psychodermatology
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- Phytoconstituents and Antioxidant Profiling of Avicennia marina (Forsk.) Vierh. Heartwood Extract Sourced from Bagan Kuala: A Novel Natural Source for Radical Scavenging Applications
- MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS
- การศึกษาแบบสุ่มและทดสอบความไม่ด้อยกว่า ของ ยาไมนอกซิดิลชนิดรับประทานขนาด 1.25 มิลลิกรัมต่อวัน เปรียบเทียบกับ ยาทา5%ไมนอกซิดิลในการรักษาโรคผมบางจากพันธุกรรมในเพศหญิง